Nalini Jayaprakash

Sustained response and prevention of damage progression in patients with neonatal‐onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three‐ and five‐year outcomes

Cailin H. Sibley, N. Plass, Joseph Snow et al. · Arthritis & Rheumatism · 2012 · 213 citations · Full text

Medicine, Immunology, Pediatrics +15

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Brigitte C. Widemann, Frank M. Balis, AeRang Kim et al. · Journal of Clinical Oncology · 2010 · 173 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Phase I Trial and Pharmacokinetic Study of the Farnesyltransferase Inhibitor Tipifarnib in Children With Refractory Solid Tumors or Neurofibromatosis Type I and Plexiform Neurofibromas

Brigitte C. Widemann, Wanda L. Salzer, R.J. Arceci et al. · Journal of Clinical Oncology · 2006 · 145 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors

Elizabeth Fox, Richard Aplenc, Rochelle Bagatell et al. · Journal of Clinical Oncology · 2010 · 108 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Efficacy of Glucarpidase (Carboxypeptidase <scp>G</scp> 2) in Patients with Acute Kidney Injury After High‐Dose Methotrexate Therapy

Brigitte C. Widemann, Stefan Schwartz, Nalini Jayaprakash et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2013 · 91 citations

Pharmacy, Pharmacology, Pharmacotherapy +16